resveratrol has been researched along with raltegravir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J | 1 |
| Botta, L; Brai, A; Calandro, P; Canducci, F; Carda, M; Chiariello, M; Falomir, E; Maccari, G; MartÃ-Centelles, R; Tiberi, M; Zamperini, C | 1 |
2 other study(ies) available for resveratrol and raltegravir
| Article | Year |
|---|---|
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship | 2016 |
One drug for two targets: Biological evaluation of antiretroviral agents endowed with antiproliferative activity.
Topics: Anti-Retroviral Agents; Cell Survival; Gene Expression; HIV-1; HT29 Cells; Humans; MCF-7 Cells; Microsomes, Liver; Proto-Oncogene Proteins c-myc; Telomerase | 2017 |